Zyclara Approval History

  • FDA approved: Yes (First approved March 25th, 2010)
  • Brand name: Zyclara
  • Generic name: imiquimod
  • Company: Graceway Pharmaceuticals, LLC
  • Treatment for: Keratosis, Condylomata Acuminata

Zyclara (imiquimod) is an immune response modifier indicated for the topical treatment of actinic keratoses and external genital warts.

FDA Approval History for Zyclara

DateArticle
Jul 29, 2011Approval FDA Approves Zyclara (imiquimod) Cream, 2.5% for the Treatment of Actinic Keratoses
Mar 25, 2011Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of External Genital Warts
Mar 29, 2010Approval FDA Approves Zyclara (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web5)